ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,269Top JournalHybrid

Best Practice & Research Clinical Endocrinology & Metabolism

Abbreviation (ISO):BEST PRACT RES CL EN
•
Identifier (ISSN):1521-690X(Print)/1532-1908(Online)
•
Publisher:Bailliere Tindall Ltd
Clarivate IF (2026)
6.9↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Best Practice & Research Clinical Endocrinology & Metabolism

WoS Q1
257104.4220183.8120193.720204.6920215.6720227.420236.120246.120256.92026
Annual Impact Factor Metric
Current (2026):6.9
Scopus SJR & RankScopus Q1
2.139
#1,269

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
138

138 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
55articles/year
33.73% Gold OA•80% Original Research

Aims & Scope

Best Practice & Research Clinical Endocrinology & Metabolism is a topical serial publication integrating the results from the latest original research into practical, evidence-based review articles that seek to address the key clinical issues of diagnosis, treatment and patient management. Each issue follows a problem-orientated approach which focuses on the key questions to be addressed, clearly defining what is known and highlighting topics for future research. Management is described in practical terms so that it can be applied to the individual patient. The series is aimed at the physician either in practice or in training.

Topics Covered (Recognized by AI)
Medicine89.1%Biology86.3%Internal medicine82.5%Endocrinology76.6%Genetics65.6%Chemistry61.7%Biochemistry58.4%Pathology51.3%Hormone33.4%Psychology25.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank25/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank16/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.9
Articles / Year53
Total Citations10
2025
IF6.1
Articles / Year69
Total Citations236
2024
IF6.1
Articles / Year50
Total Citations385
2023
IF7.4
Articles / Year72
Total Citations1,242
2022
IF5.667
Articles / Year75
Total Citations2,025

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,269Scopus Q1SCImago Profile
Scopus Coverage:1999-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.139

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.61

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,682 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,271
3-Year Documents181
Citable Documents164

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate55.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ1
Endocrinology, Diabetes and MetabolismQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Best Practice & Research Clinical Endocrinology & Metabolism (abbr: BEST PRACT RES CL EN, ISSN: 1521-690X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Bailliere Tindall Ltd in England. The periodical holds a Journal Impact Factor (JIF) of 6.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.139 (Q1), an H-index of 138.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 55 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,682 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Bailliere Tindall Ltd
Publication Language
English
Frequency
Quarterly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d64675ef-4b37-4ccb-87fa-dd6d7bc264de
Database Updated: 2026-10-16